Reprogramming of DPSC to Induced Pluripotent Stem Cells

A primary objective in cell biology research is to induce a true regenerative response from pluripotent cells, which have the potential to develop into virtually any cell type. Takahashi and Yamanaka revolutionized the field by demonstrating that somatic mammalian cells could be reprogrammed into a pluripotent state using just four transcription factors, resulting in the creation of induced pluripotent stem cells (iPSCs). This groundbreaking technology circumvents the ethical and legal concerns associated with embryonic stem cells and holds an immense potential for clinical applications. This chapter presents a concise overview of the historical pursuit of somatic cell reprogramming and the subsequent application of induced pluripotent stem cells (iPSCs). It explores not only disease-specific iPSCs but also their broader potential applications. The chapter addresses the challenges hindering the therapeutic use of human iPSCs and proposes potential solutions. Organoids, considered the most promising advancement in iPSC research, offer a key to unlocking the full potential of stem cell discovery through the investigation of complex cellular interactions. The chapter discusses the applications and potential benefits of organoid research. Lastly, it explores the reprogramming of dental pulp stem cells into iPSCs and examines the potential need for this approach in dental regenerative therapies.